ReproCELL to Enter Collaborative R&D on Human iPS Cell Derived Hepatocytes

2011.01.05

ReproCELL announces today that it will start a collaboration with the National Institute of Biomedical Innovation (NIBIO) to develop human iPS cell-derived hepatocytes for in vitro drug screening, hepatic toxocity and drug metabolism.
See the news